| Bioactivity | Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibiotic. Dirithromycin is active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis[1][2]. | ||||||||||||
| Invitro | Dirithromycin possesses an in vitro spectrum of antimicrobial activity which is similar to that of Erythromycin[2].Dirithromycin exhibits excellent in vitro activity against several strains of Legionella, with MICs of ~1.0 and Helicobacter pytori, with MICs of <0.5 μg/mL[2]. | ||||||||||||
| Name | Dirithromycin | ||||||||||||
| CAS | 62013-04-1 | ||||||||||||
| Formula | C42H78N2O14 | ||||||||||||
| Molar Mass | 835.07 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Dirithromycin
CAS: 62013-04-1 F: C42H78N2O14 W: 835.07
Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibioti
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.